208 related articles for article (PubMed ID: 25693879)
1. Cost of acute stroke care for patients with atrial fibrillation compared with those in sinus rhythm.
Ali AN; Howe J; Abdel-Hafiz A
Pharmacoeconomics; 2015 May; 33(5):511-20. PubMed ID: 25693879
[TBL] [Abstract][Full Text] [Related]
2. The cost savings of newer oral anticoagulants in atrial fibrillation-related stroke prevention
.
Masbah N; Macleod MJ
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):220-230. PubMed ID: 28025962
[TBL] [Abstract][Full Text] [Related]
3. Incidence and cost of stroke and hemorrhage in patients diagnosed with atrial fibrillation in France.
Cotté FE; Chaize G; Kachaner I; Gaudin AF; Vainchtock A; Durand-Zaleski I
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):e73-83. PubMed ID: 24119623
[TBL] [Abstract][Full Text] [Related]
4. The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation.
Amorosi SL; Armstrong S; Da Deppo L; Garfield S; Stein K
Europace; 2014 Aug; 16(8):1131-6. PubMed ID: 24687964
[TBL] [Abstract][Full Text] [Related]
5. Acute hospital, community, and indirect costs of stroke associated with atrial fibrillation: population-based study.
Hannon N; Daly L; Murphy S; Smith S; Hayden D; Ní Chróinín D; Callaly E; Horgan G; Sheehan O; Honari B; Duggan J; Kyne L; Dolan E; Williams D; Wiley M; Kelly PJ
Stroke; 2014 Dec; 45(12):3670-4. PubMed ID: 25358697
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of rivaroxaban for stroke prevention in German patients with atrial fibrillation.
Mensch A; Stock S; Stollenwerk B; Müller D
Pharmacoeconomics; 2015 Mar; 33(3):271-83. PubMed ID: 25404426
[TBL] [Abstract][Full Text] [Related]
7. Hospitalization expenses of acute ischemic stroke patients with atrial fibrillation relative to those with normal sinus rhythm.
Li J; Luo W
J Med Econ; 2017 Feb; 20(2):114-120. PubMed ID: 27559816
[TBL] [Abstract][Full Text] [Related]
8. The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study.
Brüggenjürgen B; Rossnagel K; Roll S; Andersson FL; Selim D; Müller-Nordhorn J; Nolte CH; Jungehülsing GJ; Villringer A; Willich SN
Value Health; 2007; 10(2):137-43. PubMed ID: 17391422
[TBL] [Abstract][Full Text] [Related]
9. The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.
Li X; Tse VC; Au-Doung LW; Wong ICK; Chan EW
Europace; 2017 Jun; 19(6):937-947. PubMed ID: 27209573
[TBL] [Abstract][Full Text] [Related]
10. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany.
McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B
Value Health; 2009; 12(2):293-301. PubMed ID: 18657103
[TBL] [Abstract][Full Text] [Related]
11. Societal Costs of First-Incident Ischemic Stroke in Patients with Atrial Fibrillation-A Danish Nationwide Registry Study.
Jakobsen M; Kolodziejczyk C; Fredslund EK; Poulsen PB; Dybro L; Johnsen SP
Value Health; 2016 Jun; 19(4):413-8. PubMed ID: 27325333
[TBL] [Abstract][Full Text] [Related]
12. Impact of atrial fibrillation on stroke-related healthcare costs.
Sussman M; Menzin J; Lin I; Kwong WJ; Munsell M; Friedman M; Selim M
J Am Heart Assoc; 2013 Nov; 2(6):e000479. PubMed ID: 24275631
[TBL] [Abstract][Full Text] [Related]
13. Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated?
Miller PS; Andersson FL; Kalra L
Stroke; 2005 Feb; 36(2):360-6. PubMed ID: 15637326
[TBL] [Abstract][Full Text] [Related]
14. Review of economics and cost-effectiveness analyses of anticoagulant therapy for stroke prevention in atrial fibrillation in the US.
von Schéele B; Fernandez M; Hogue SL; Kwong WJ
Ann Pharmacother; 2013 May; 47(5):671-85. PubMed ID: 23606551
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
Chevalier J; Delaitre O; Hammès F; de Pouvourville G
Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
[TBL] [Abstract][Full Text] [Related]
16. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China.
Wen L; Wu J; Feng L; Yang L; Qian F
Curr Med Res Opin; 2017 Oct; 33(10):1789-1794. PubMed ID: 28657348
[TBL] [Abstract][Full Text] [Related]
17. The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001.
Ghatnekar O; Glader EL
Value Health; 2008; 11(5):862-8. PubMed ID: 18489491
[TBL] [Abstract][Full Text] [Related]
18. Cost efficiency of anticoagulation with warfarin to prevent stroke in medicare beneficiaries with nonvalvular atrial fibrillation.
Mercaldi CJ; Ciarametaro M; Hahn B; Chalissery G; Reynolds MW; Sander SD; Samsa GP; Matchar DB
Stroke; 2011 Jan; 42(1):112-8. PubMed ID: 21148442
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Lip GY; Kongnakorn T; Phatak H; Kuznik A; Lanitis T; Liu LZ; Iloeje U; Hernandez L; Dorian P
Clin Ther; 2014 Feb; 36(2):192-210.e20. PubMed ID: 24508420
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.
Lee S; Anglade MW; Pham D; Pisacane R; Kluger J; Coleman CI
Am J Cardiol; 2012 Sep; 110(6):845-51. PubMed ID: 22651881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
